SARS CoV 2 Infection
80
9
16
40
Key Insights
Highlights
Success Rate
95% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
2.5%
2 terminated out of 80 trials
95.2%
+8.7% vs benchmark
8%
6 trials in Phase 3/4
15%
6 of 40 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 40 completed trials
Clinical Trials (80)
CARE-ID: Dynamics of Respiratory Infections in Children and Transmission in Households and Schools
Pancoronavirus Vaccine Study in Healthy Adults
Exercise in Child Health
Open-label, Multi-centre, Non-Inferiority Study of Safety and Immunogenicity of BIMERVAX for the Prevention of COVID-19 in Adolescents From 12 Years to Less Than 18 Years of Age.
Evaluating Safety and Immune Response of Janssen, Moderna, Pfizer/BNT, and Novavax COVID-19 Vaccines for Same and Mixed Boosters in Adolescents and Adults Aged 12-64 With and Without HIV in Kenya, DRC, and Rwanda
The Efficacy of the 2023-2024 Updated COVID-19 Vaccines Against COVID-19 Infection
Effect of 2-HOBA in Persistent Immune Activation in Long COVID POTS
Cardiovascular Autonomic and Immune Mechanism of Post COVID-19 Tachycardia Syndrome
Development and Validation of (Bio)Sensors for the Identification of Pathogens
Phase II Study of AVX/COVID-12 Vaccine in Subjects With Prior SARS-CoV-2 Immunity Evidence
Safety and Effectiveness of a Remdesivir Treatment to Prevent Severe COVID-19 in Kidney Transplant Patients
A Phase IIb/III Clinical Trial to Assess Safety and Immunogenicity of a COVID-19 Vaccine Booster Dose in Immunosupressed Adults.
NIH RECOVER Tissue Pathology: Understanding the Long-Term Impact of COVID-19
Study to Evaluate the Safety & Immunogenicity of IMNN-101 Administered in Healthy Adults Previously Vaccinated Against SARS-CoV-2
COVID-19 Transmission and Morbidity in Malawi
Sars-COV-2 (COVID-19) Immunity in immunoCOmpromised Populations
Efficacy, Immunogenicity, and Safety of the Inactivated COVID-19 Vaccine (TURKOVAC) in Healthy Pregnant Women
CU-COMMITS: COVID-19 Care in Black and Latino Communities and Households. Clinical and Molecular Outcomes of SARS-CoV-2
ARMOR-Household: Characterizing Transmission of COVID-19 in Households of SARS-CoV-2 Index Cases
Transplacental Transmission of RSV (TTRSV)